amikacin has been researched along with pantothenic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Çıkrıkçıoğlu, MA; Çoban, G; Doğan, EE; Döner, B; Ekinci, İ; Erkoç, R; Hamdard, J; Karatoprak, C; Kazancıoğlu, R; Özer, ÖF | 1 |
2 other study(ies) available for amikacin and pantothenic acid
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Protective effect of dexpanthenol against nephrotoxic effect of amikacin: An experimental study.
Topics: Amikacin; Animals; Antioxidants; Edema; Epithelium; Female; Kidney; Kidney Diseases; Oxidants; Oxidative Stress; Pantothenic Acid; Protective Agents; Rats; Rats, Wistar | 2017 |